Buy EVISTA Online

Evista is a brand name for the medication raloxifene hydrochloride. It is a selective estrogen receptor modulator (SERM) used primarily in the treatment and prevention of osteoporosis in postmenopausal women. Below is a general description of Evista:

Composition and Mechanism of Action:

• Active Ingredient: Raloxifene hydrochloride is the active ingredient in Evista.
• SERM: Evista is classified as a selective estrogen receptor modulator. It acts selectively on estrogen receptors in certain tissues, mimicking the effects of estrogen in some areas of the body while blocking its effects in others.

Indications:

• Osteoporosis: Evista is commonly prescribed for the prevention and treatment of osteoporosis in postmenopausal women. It helps increase bone density and reduce the risk of fractures.
• Breast Cancer Risk Reduction: Evista is also approved for the reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.

Dosage and Administration:

• The dosage of Evista may vary depending on the specific medical condition being treated or prevented. It is typically taken orally in the form of a tablet.

Monitoring:

• Regular monitoring, including bone density tests and breast exams, may be recommended during the course of treatment.

Side Effects:

• Common side effects of Evista may include hot flashes, leg cramps, swelling, and flu-like symptoms. Serious side effects, although rare, may include an increased risk of blood clots.

Contraindications:

• Evista is generally contraindicated in individuals with a history of blood clots, stroke, liver disease, or those who are pregnant.

Precautions:

• Evista should be used with caution in individuals with a history of cardiovascular disease. Smoking and the use of estrogen-containing medications may increase the risk of certain side effects.

Patient Counseling:

• Patients prescribed Evista should be educated about its proper use, potential side effects, and the importance of regular follow-up with a healthcare provider.

Pregnancy and Breastfeeding:

• Evista is not intended for use in premenopausal women, pregnant women, or women who are breastfeeding.

It’s crucial to note that the information provided here is a general overview, and specific details regarding the use of Evista should be discussed with a healthcare professional. The medication should be used under the guidance and supervision of a qualified healthcare provider based on the individual’s medical history and specific health needs.